For advanced type 2 diabetes with significant beta cell failure, or for type 1 diabetes, Tresiba (or another insulin) is essential and often superior to or required in addition to GLP-1 therapy
Its unique chemical properties and mechanism of action make it valuable for treating various conditions, from methemoglobinemia to its potential use in neurodegenerative disorders
After the initial trial, participants were randomly assigned to either an LC group (2 g twice daily for 7 days) or a placebo group, consuming citrus drinks
"Riboflavin-Responsive Trimethylaminuria in a Patient with Homocystinuria on Betaine Therapy"
But it does cover GLP-1s prescribed to reduce the risk of heart attack and stroke due to cardiovascular disease and obesity or being overweight
These drugs mimic the natural hormone GLP-1, which helps regulate insulin, blood sugar levels, and appetite